Malignant peripheral nerve sheath tumor epidemiology and demographics: Difference between revisions
Marjan Khan (talk | contribs) (→Gender) |
Marjan Khan (talk | contribs) (→Age) |
||
| Line 12: | Line 12: | ||
==Age== | ==Age== | ||
* | *Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally .<ref name="pmid25130403">{{cite journal| author=Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS| title=Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. | journal=Pediatr Blood Cancer | year= 2014 | volume= 61 | issue= 11 | pages= 1955-60 | pmid=25130403 | doi=10.1002/pbc.25149 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25130403 }} </ref> | ||
==Gender== | ==Gender== | ||
Latest revision as of 14:16, 23 August 2019
|
Malignant peripheral nerve sheath tumor Microchapters |
|
Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Malignant peripheral nerve sheath tumor epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor epidemiology and demographics |
|
FDA on Malignant peripheral nerve sheath tumor epidemiology and demographics |
|
CDC on Malignant peripheral nerve sheath tumor epidemiology and demographics |
|
Malignant peripheral nerve sheath tumor epidemiology and demographics in the news |
|
Blogs on Malignant peripheral nerve sheath tumor epidemiology and demographics |
|
Directions to Hospitals Treating Malignant peripheral nerve sheath tumor |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]
Overview
Malignant peripheral nerve sheath tumors comprise ∼2% of all sarcomas whichare a small fraction of a group of cancers that affect 5 people per million per year. The incidence of malignant peripheral nerve sheath tumor is approximately 0.1 per 100,000 individuals worldwide.[1] The incidence of malignant peripheral nerve sheath tumor increases with age.[1] Malignant peripheral nerve sheath tumor affects men and women equally.[2]
Incidence
- Malignant peripheral nerve sheath tumors comprise ∼2% of all sarcomas whichare a small fraction of a group of cancers that affect 5 people per million per year.
- The incidence of malignant peripheral nerve sheath tumor is approximately 0.1 per 100,000 individuals worldwide.[1]
- Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection.
- Half of MPNSTs are associated with neurofibromatosis type 1 (NF1), the autosomal dominant condition that, affecting 1 in 3000 live births, represents the most common human cancer genetic predisposition syndrome.
Age
- Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally .[1]
Gender
- Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally.[2]
References
- ↑ 1.0 1.1 1.2 1.3 Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS (2014). "Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population". Pediatr Blood Cancer. 61 (11): 1955–60. doi:10.1002/pbc.25149. PMID 25130403.
- ↑ 2.0 2.1 Malignant peripheral nerve sheath tumor. Radiopaedia 2015. http://radiopaedia.org/articles/malignant-peripheral-nerve-sheath-tumour